Group One Trading
NUVB icon

Group One Trading’s Nuvation Bio NUVB Stock Holding History

Group One Trading’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
77,100
+20,900
+37% +$102K ﹤0.01% 3618
2026
Q1 		$241K Sell
56,200
-395,500
-88% -$2.2M ﹤0.01% 3965
2025
Q4 		$4.05M Buy
451,700
+407,400
+920% +$2.52M 0.01% 1688
2025
Q3 		$164K Sell
44,300
-18,600
-30% -$50.7K ﹤0.01% 4891
2025
Q2 		$123K Buy
62,900
+62,800
+62,800% +$131K ﹤0.01% 4793
2025
Q1 		$176 Buy
+100
New +$228 ﹤0.01% 7381
2024
Q3 		– Sell
-500
Closed -$1.46K – 7132
2024
Q2 		$1.46K Sell
500
-200
-29% -$610 ﹤0.01% 6285
2024
Q1 		$2.55K Buy
+700
New +$1.34K ﹤0.01% 6433
2023
Q3 		– Sell
-1,100
Closed -$1.98K – 8084
2023
Q2 		$1.98K Buy
+1,100
New +$1.87K ﹤0.01% 7096
2022
Q1 		– Sell
-24,600
Closed -$209K – 8471
2021
Q4 		$209K Hold
24,600
– – ﹤0.01% 5045
2021
Q3 		$245K Buy
24,600
+24,000
+4,000% +$218K ﹤0.01% 4954
2021
Q2 		$6K Buy
+600
New +$6.84K ﹤0.01% 7705

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Group One Trading's NUVB Position: Q2 2026 in Review

Group One Trading increased its Nuvation Bio (NUVB) stake by 178% in Q2 2026, buying an estimated $618K and bringing the position to 197,470 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Group One Trading first reported a position in NUVB in Q2 2021 and has held it in 8 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Group One Trading held 197,470 shares of Nuvation Bio worth $1.12M as of Q2 2026.
  • Group One Trading bought 126,389 Nuvation Bio shares in Q2 2026, an estimated $618K.
  • Nuvation Bio made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2757 holding.
  • Group One Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 8 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.